Caspofungin Acetate (Athenex Pharmaceutical Division, LLC.)


Welcome to the PulseAid listing for the Caspofungin Acetate drug offered from Athenex Pharmaceutical Division, LLC.. This Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Athenex Pharmaceutical Division, LLC.
NON-PROPRIETARY NAME: caspofungin acetate
SUBSTANCE NAME: CASPOFUNGIN ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-10-04
END MARKETING DATE: 0000-00-00


Caspofungin Acetate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCaspofungin Acetate from Athenex Pharmaceutical Division, LLC.
LABELER NAME: Athenex Pharmaceutical Division, LLC.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/10.8mL)
START MARKETING DATE: 2017-10-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70860-106_a17f552e-fa3c-412a-b294-3fd310eee452
PRODUCT NDC: 70860-106
APPLICATION NUMBER: ANDA207092

Other CASPOFUNGIN ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Athenex Pharmaceutical Division, LLC.Caspofungin Acetate
Fresenius Kabi USA, LLCCaspofungin Acetate
Gland Pharma LimitedCaspofungin Acetate
Merck Sharp & Dohme Corp.CANCIDAS
Mylan Institutional LLCCaspofungin acetate